Coronavirus vaccine trials of mRNA-1273 from Moderna has shown very promising results. The vaccine tests were conducted on healthy subjects between ages 18 and 55 and after two doses, they developed more antibodies than recovered people within 43 days.
Moderna says phase 3 trials to begin in June-July. If successful, vaccine will be available by year end pic.twitter.com/DTqyx4hWLu
— Rishi Bagree 🇮🇳 (@rishibagree) May 19, 2020
Moderna is expecting to start phase 2 trials for its coronavirus vaccine and the phase 3 trials can start bu July. It might be possible that the COVID-19 vaccine could be ready before the end of this year, and Trump is already making arrangements to distribute the vaccine by using the American military forces.
Moderna mRNA-1273 Coronavirus Vaccine Trails shows Promising Results
The trial for mRNA-1273 began where mRNA stands for messenger RNA started in March at Moderna biotech. The early demonstrations for the vaccination create an immune response of the same power caused by the natural infection with a dose as low as 25 µg. It has been seen that mRNA-1273 can prevent viral replication and COVID-19 disease by selective doses.
There is a higher level of antibodies in the test subjects compared to the amount found in the blood serum of COVID-19 recovered patients. Moderna team is now focusing on phase 3 trials in July and at this rate, the coronavirus vaccine can be developed around the end of this year.
Trump says COVID-19 Vaccine will be Available by the End of this Year
President Donald Trump says that he is confident that the coronavirus vaccine will be available by the end of this year. The vaccine will enter mass production as soon as it is cleared by the FDA and other medical experts. Trump has also announced that he will mobilize the military to distribute the coronavirus vaccine to all US citizens. The US President has been blaming China for the COVID-19 outbreak and will take strict action against the country.